Marathon Trading Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Marathon Trading Investment Management's PFE Position: Q3 2025 in Review
Marathon Trading Investment Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 17,880 shares — an estimated $441K sold.
Marathon Trading Investment Management first reported a position in PFE in Q2 2013 and held it in 19 quarters. The position peaked at $4.8M in Q4 2023. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Marathon Trading Investment Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Marathon Trading Investment Management sold 17,880 Pfizer shares in Q3 2025, an estimated $441K.
- Marathon Trading Investment Management first reported a position in Pfizer in Q2 2013 and held it in 19 quarters.
- Marathon Trading Investment Management's Pfizer position peaked at $4.8M in Q4 2023.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Marathon Trading Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.